Related Experiment Video
Updated: Dec 27, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Long noncoding RNA RHPN1-AS1 promotes colorectal cancer progression via targeting miR-7-5p/OGT axis
Wei Zheng1, Hui Li2, Hui Zhang1
11Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, 450003 Henan China.
Background:
Rhophilin Rho GTPase binding protein 1 antisense RNA 1 (RHPN1-AS1) is a newly discovered oncogene in several diseases, such as breast cancer, non-small cell lung cancer and uveal melanoma. Nevertheless, its molecular role in colorectal cancer (CRC) remains unknown. This paper explored the role of RHPN1-AS1 in CRC progression.
Methods:
qRT-PCR was used to detect relevant RNAs expression. CCK-8, EdU, flow cytometry, Transwell and western blot assays were performed to investigate the function of RHPN1-AS1 in CRC cells. Xenograft model was constructed to evaluate the effects of RHPN1-AS1 on tumor growth in vivo. Mechanical experiments were performed to investigate the relationship between relative genes.
Results:
RHPN1-AS1 was significantly overexpressed in CRC cell lines. Knockdown of RHPN1-AS1 could inhibit cell proliferation, while stimulating cell apoptosis in vitro. Cell migration and invasion abilities were greatly suppressed after silencing RHPN1-AS1. Besides, signal transducer and activator of transcription 3 (STAT3) served as transcription factor of RHPN1-AS1. Moreover, miR-7-5p was identified as a target of RHPN1-AS1 and was negatively regulated by RHPN1-AS1 in CRC. MiR-7-5p inhibition rescued the oncogenic function of RHPN1-AS1. Additionally, O-GlcNAcylation transferase (OGT) was the downstream target of miR-7-5p. OGT overexpression could abrogate the anti-tumor effects of RHPN1-AS1 knockdown on CRC.
Conclusion:
RHPN1-AS1 regulates CRC by mediating OGT through sponging miR-7-5p, suggesting that RHPN1-AS1 might be a potential therapeutic target for CRC.
Insights
Rhophilin Rho GTPase binding protein 1 antisense RNA 1 (RHPN1-AS1) promotes colorectal cancer (CRC) progression by regulating O-GlcNAcylation transferase (OGT) via sponging miR-7-5p. Silencing RHPN1-AS1 inhibits CRC growth, suggesting it as a potential therapeutic target.
Area of Science:
- Molecular oncology
- Genetics
- Cancer biology
Background:
- Rhophilin Rho GTPase binding protein 1 antisense RNA 1 (RHPN1-AS1) is an emerging oncogene implicated in various cancers.
- Its specific role in colorectal cancer (CRC) pathogenesis was previously uncharacterized.
Purpose of the Study:
- To elucidate the molecular function and regulatory mechanisms of RHPN1-AS1 in colorectal cancer progression.
- To investigate RHPN1-AS1 as a potential therapeutic target for CRC.
Main Methods:
- Quantitative reverse transcription PCR (qRT-PCR) for RNA expression analysis.
- Cell proliferation (CCK-8, EdU), apoptosis (flow cytometry), migration, and invasion assays in CRC cells.
- Xenograft models for in vivo tumor growth assessment.
- Western blot and mechanistic studies to explore gene interactions.
Main Results:
- RHPN1-AS1 is significantly overexpressed in CRC cell lines and promotes proliferation, survival, migration, and invasion.
- RHPN1-AS1 acts as a molecular sponge for miR-7-5p, leading to the upregulation of its downstream target, O-GlcNAcylation transferase (OGT).
- STAT3 was identified as a transcription factor for RHPN1-AS1, and OGT overexpression reversed the anti-tumor effects of RHPN1-AS1 knockdown.
Conclusions:
- RHPN1-AS1 promotes colorectal cancer progression by mediating OGT expression through sponging miR-7-5p.
- RHPN1-AS1 represents a promising therapeutic target for colorectal cancer treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Experimental RNAi
piRNA - Piwi-interacting RNAs